Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Clinical Study of Synaptic Plasticity-based Lencanumab for the Treatment of Early Alzheimer's Disease

NCT06871839 is registered in ClinicalTrials.gov with Cuibai Wei，Clinical Professor as lead sponsor.

NCT NCT06871839
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06871839 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Clinical Study of Synaptic Plasticity-based Lencanumab for the Treatment of Early Alzheimer's Disease
Lead sponsor
Cuibai Wei，Clinical Professor
Phase
Observational
Overall status
Recruiting
Start date
March 10, 2025
Completion date
December 31, 2026
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease, functional magnetic resonance imaging, lecanemab